These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18508458)

  • 1. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
    Salamone JD; Betz AJ; Ishiwari K; Felsted J; Madson L; Mirante B; Clark K; Font L; Korbey S; Sager TN; Hockemeyer J; Muller CE
    Front Biosci; 2008 May; 13():3594-605. PubMed ID: 18508458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
    Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
    Correa M; Wisniecki A; Betz A; Dobson DR; O'Neill MF; O'Neill MJ; Salamone JD
    Behav Brain Res; 2004 Jan; 148(1-2):47-54. PubMed ID: 14684247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    Collins-Praino LE; Paul NE; Ledgard F; Podurgiel SJ; Kovner R; Baqi Y; Müller CE; Senatus PB; Salamone JD
    Eur J Neurosci; 2013 Jul; 38(1):2183-91. PubMed ID: 23600953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
    Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
    Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
    Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
    Podurgiel SJ; Spencer T; Kovner R; Baqi Y; Müller CE; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2016 Jan; 140():62-7. PubMed ID: 26459156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of adenosine A
    Kosmowska B; Ossowska K; Wardas J
    Behav Brain Res; 2022 Jan; 417():113585. PubMed ID: 34536428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
    Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
    Collins LE; Sager TN; Sams AG; Pennarola A; Port RG; Shahriari M; Salamone JD
    Pharmacol Biochem Behav; 2012 Jan; 100(3):498-505. PubMed ID: 22037410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.
    Salamone JD; Ishiwari K; Betz AJ; Farrar AM; Mingote SM; Font L; Hockemeyer J; Müller CE; Correa M
    Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S130-4. PubMed ID: 18585081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
    Podurgiel S; Collins-Praino LE; Yohn S; Randall PA; Roach A; Lobianco C; Salamone JD
    Pharmacol Biochem Behav; 2013 Apr; 105():105-11. PubMed ID: 23360954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.
    Ishiwari K; Madson LJ; Farrar AM; Mingote SM; Valenta JP; DiGianvittorio MD; Frank LE; Correa M; Hockemeyer J; Müller C; Salamone JD
    Behav Brain Res; 2007 Mar; 178(2):190-9. PubMed ID: 17223207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making.
    Pardo M; Paul NE; Collins-Praino LE; Salamone JD; Correa M
    Pharmacol Biochem Behav; 2020 Nov; 198():173035. PubMed ID: 32910928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremulous jaw movements in rats: a model of parkinsonian tremor.
    Salamone JD; Mayorga AJ; Trevitt JT; Cousins MS; Conlan A; Nawab A
    Prog Neurobiol; 1998 Dec; 56(6):591-611. PubMed ID: 9871939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
    Ishiwari K; Betz A; Weber S; Felsted J; Salamone JD
    Pharmacol Biochem Behav; 2005 Feb; 80(2):351-62. PubMed ID: 15680188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.
    Wisniecki A; Correa M; Arizzi MN; Ishiwari K; Salamone JD
    Psychopharmacology (Berl); 2003 Nov; 170(2):140-9. PubMed ID: 12827348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Varty GB; Hodgson RA; Pond AJ; Grzelak ME; Parker EM; Hunter JC
    Psychopharmacology (Berl); 2008 Oct; 200(3):393-401. PubMed ID: 18594798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
    Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
    Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
    Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.